Skip to content
HeyJared

Vedant Shrivastav

Reporter · IN

Indexed articles, last 90 days
2
Latest publication
Oct 1, 2026
Outlet visibility, for Freepressjournal
Top 100K sites
Earliest in this view
Sep 8, 2026

Latest articles

  1. Article · Oct 1, 2026 · Vedant Shrivastav

    Aurobindo Pharma Enters US Dermatology Market With Launch Of ADQUEY Ointment For Atopic Dermatitis (opens the original)

    Excerpt · Positive tone · English

    Read excerpt

    Hyderabad-headquartered pharmaceutical giant Aurobindo Pharma Ltd announced that its US specialty subsidiary, Acrotech Biopharma Inc., has officially launched ADQUEY ointment across the United States. The milestone that came on Wednesday marks the Indian healthcare major’s strategic entry into the lucrative American dermatology segment.ADQUEY is a non-steroidal, topical phosphodiesterase-4 (PDE4) inhibitor specifically approved for the treatment of mild-to-moderate atopic dermatitis in adults an

  2. Article · Sep 8, 2026 · Vedant Shrivastav

    Ashish Joshi FIR Row: Delhi Court Hearing Today On Ex-bureaucrat’s Plea Over Delayed FIR Copy (opens the original)

    Excerpt · English

    Read excerpt

    The legal battle surrounding retired bureaucrat Ashish Joshi comes up for hearing today before Chief Judicial Magistrate Mridul Gupta at Delhi's Patiala House Court. Joshi approached the court demanding an immediate copy of the First Information Report (FIR) registered against him by the Delhi Police Special Cell after he was picked up during his morning walk and subjected to a nine-hour interrogation regarding his social media activity on X. While law enforcement provided him with a copy of the

Publishing over time

Last 90 days. Choose a month to open its work.

Recurring subjects

Named in the text we hold. One piece can cover several.

Audience

Top 100K sites

For Freepressjournal, the outlet · Measured Aug 1, 2026

Website popularity band, not a count of readers or article views.

About this data

Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.

Identity or attribution wrong? Suggest a correction.

See coverage about Vedant Shrivastav